PulseExploreJournal ClubDebatesTrendingResearchersJournals
Instagram
HomeExploreJournal ClubTrending
Synapse
⌘+K
Synapse
April 19, 2026CNS Neuroscience & Therapeutics0 citationsOpen Access

Genetic Association of Sexual Behavior, Sildenafil, and Hormonal Contraceptives With Mental Disorders

View Full Paper
ZLZhongliang LinKZKejing ZhuRHRenke He

Key Points

  • This research investigates the genetic associations of sexual behavior and hormonal contraceptives with various mental disorders.
  • Genetic analysis of allele frequency scores (AFS and NSP) related to mental disorders.
  • SMR (summary Mendelian randomization) analysis focusing on PDE11A and PDE5A.
  • Examination of progesterone receptor expression in relation to depression risk.
  • Increased genetically predicted AFS is linked to a decrease in several mental disorders.
  • Increased genetically predicted NSP correlates with an increase in anxiety disorders and depression.
  • Evidence suggests PDE11A is a contributing factor for attention disturbances.

Abstract

We found that an increased genetically predicted AFS was associated with decreasing anxiety disorders, bipolar affective disorders, depression, disturbance of activity and attention (DAA), and post-traumatic stress disorder. An increased genetically predicted NSP was associated with increasing anxiety disorders, bipolar affective disorders, depression, and post-traumatic stress disorder. SMR analysis found that PDE11A, instead of PDE5A, a drug target for sildenafil, causes DAA. Suggestive evidence was observed regarding the positive association between progesterone receptor expression and risk of depression. Notably, given the exploratory nature of the multiple analyses, these findings require replication in independent cohorts to confirm causal relationships.

Ask AI
Helpful
Bookmark
Share
View Full Paper

Cite This Study

Lin et al. (2026) studied this question.

synapsesocial.com/papers/69e472a8010ef96374d8e9d2https://doi.org/10.1002/cns.70861
Ask AI
Helpful
Bookmark
Share
View Full Paper